Tokyo Tape
Sign in
← Em Systems

Quarterly report · Q2

4820.TEDINET S100RMQZ
Period2023-01-01 → 2023-06-30
Filed2023-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥9.8bn2023-01-01 → 2023-06-30Cons.Net sales
Revenue¥16.9bn2022-01-01 → 2022-12-31Cons.Net sales (5-year summary)
Revenue¥8.2bn2022-01-01 → 2022-06-30Cons.Net sales
Operating income¥1.1bn2023-01-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-01-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.4bn2023-01-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥2.8bn2022-01-01 → 2022-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.6bn2022-01-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-01-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.6bn2022-01-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥789m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥784m2023-01-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-01-01 → 2022-06-30Cons.Profit loss
Total assets¥27.2bnat 2023-06-30Cons.Assets
Total assets¥26.3bnat 2022-12-31Cons.Assets
Total assets¥24.8bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥7.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥6.8bnat 2022-12-31Cons.Liabilities
Net assets / equity¥19.9bnat 2023-06-30Cons.Net assets
Net assets / equity¥19.5bnat 2022-12-31Cons.Net assets
Net assets / equity¥19.1bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥6.4bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥8.9bnat 2022-12-31Cons.Cash and deposits
Cash & equivalents¥6.4bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥8.4bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.3bnat 2021-12-31dCons.Cash and cash equivalents
Operating cash flow¥371m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.5bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.2bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥577m2022-01-01 → 2022-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥295m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥661m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.3bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥876m2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥11.172023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥3.922023-04-01 → 2023-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥26.752022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥15.352022-01-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.422022-04-01 → 2022-06-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥11.132023-01-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.662022-01-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥15.312022-01-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio72.8%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.6%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 42
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30¥27m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥278m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥278m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥285m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥1.5bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥1.5bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥7m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥386m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥337m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥48m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥7.7bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥9m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥1.4bn
—segment totalrevenue2023-01-01 → 2023-06-30¥9.9bn
—segment totalrevenue external2023-01-01 → 2023-06-30¥9.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-06-30¥58m
—segment totalsegment profit2023-01-01 → 2023-06-30¥1.1bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-06-30−¥24m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30¥15m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥268m
jpcrp040300-q2r_E05155-000Care Welfare IT Systems Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥55m
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥1.1bn
jpcrp040300-q2r_E05155-000Medicine Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥184m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥347m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥328m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥19m
jpcrp040300-q2r_E05155-000Other Businessreportable segmentsegment profit2022-01-01 → 2022-06-30−¥22m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue external2022-01-01 → 2022-06-30¥6.5bn
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentrevenue intersegment2022-01-01 → 2022-06-30¥5m
jpcrp040300-q2r_E05155-000Pharmacy Receipt Computer And Related Businessreportable segmentsegment profit2022-01-01 → 2022-06-30¥1.5bn
—segment totalrevenue2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue external2022-01-01 → 2022-06-30¥8.2bn
—segment totalrevenue intersegment2022-01-01 → 2022-06-30¥24m
—segment totalsegment profit2022-01-01 → 2022-06-30¥1.3bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 541
ItemContextValueUnit
Provision for bonusesPrior1YearInstant285000000JPY
Provision for bonusesCurrentQuarterInstant406000000JPY
Contract liabilitiesPrior1YearInstant999000000JPY
Contract liabilitiesCurrentQuarterInstant1027000000JPY
Other clPrior1YearInstant666000000JPY
Other clCurrentQuarterInstant982000000JPY
Current liabilitiesPrior1YearInstant4944000000JPY
Current liabilitiesCurrentQuarterInstant5195000000JPY
Long term loans payablePrior1YearInstant－JPY
Long term loans payableCurrentQuarterInstant186000000JPY
Lease obligations nclPrior1YearInstant74000000JPY
Lease obligations nclCurrentQuarterInstant37000000JPY
Net defined benefit liabilityPrior1YearInstant1061000000JPY
Net defined benefit liabilityCurrentQuarterInstant1224000000JPY
Provision for product warranties nclPrior1YearInstant20000000JPY
Provision for product warranties nclCurrentQuarterInstant3000000JPY
Long term guarantee depositedPrior1YearInstant745000000JPY
Long term guarantee depositedCurrentQuarterInstant647000000JPY
Other nclPrior1YearInstant－JPY
Other nclCurrentQuarterInstant22000000JPY
Noncurrent liabilitiesPrior1YearInstant1901000000JPY
Noncurrent liabilitiesCurrentQuarterInstant2121000000JPY
LiabilitiesPrior1YearInstant6846000000JPY
LiabilitiesCurrentQuarterInstant7317000000JPY
Capital stockPrior1YearInstant2785000000JPY
Capital stockCurrentQuarterInstant2785000000JPY
Capital surplusPrior1YearInstant3362000000JPY
Capital surplusCurrentQuarterInstant3376000000JPY
Retained earningsPrior1YearInstant15199000000JPY
Retained earningsCurrentQuarterInstant15423000000JPY
Treasury stockPrior1YearInstant-2017000000JPY
Treasury stockCurrentQuarterInstant-1990000000JPY
Shareholders equityPrior1YearInstant19329000000JPY
Shareholders equityCurrentQuarterInstant19594000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant35000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant97000000JPY
Foreign currency translation adjustmentPrior1YearInstant85000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant108000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-26000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-23000000JPY
Valuation and translation adjustmentsPrior1YearInstant94000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant183000000JPY
Subscription rights to sharesPrior1YearInstant55000000JPY
Subscription rights to sharesCurrentQuarterInstant56000000JPY
Non controlling interestsPrior1YearInstant23000000JPY
Non controlling interestsCurrentQuarterInstant19000000JPY
Net assetsPrior1YearInstant19503000000JPY
Net assetsCurrentQuarterInstant19852000000JPY
Liabilities and net assetsPrior1YearInstant26349000000JPY
Liabilities and net assetsCurrentQuarterInstant27170000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass